05.03.2013 Views

national-clinical-guidelines-for-stroke-fourth-edition

national-clinical-guidelines-for-stroke-fourth-edition

national-clinical-guidelines-for-stroke-fourth-edition

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Mitchell PH, Veith RC, Becker KJ, Buzaitis A, Cain KC, Fruin M,<br />

Tirschwell D, Teri L (2009) Brief psychosocial-behavioral<br />

intervention with antidepressant reduces post<strong>stroke</strong><br />

depression significantly more than usual care with<br />

antidepressant. Stroke 40 (9): 3073–8.<br />

Mohan KM, Wolfe CDA, Rudd AG, Heuschmann PU,<br />

Kolominsky-Rabas PL, Grieve AP (2011) Risk and cumulative<br />

risk of <strong>stroke</strong> recurrence. Stroke 42 (5): 1489–94.<br />

Moher D, Cook DJ, Eastwood S et al <strong>for</strong> the QUOROM group<br />

(1999) Improving the quality of reporting of meta-analysis of<br />

randomized controlled trials: The QUOROM statement.<br />

Lancet 354: 1896–1900.<br />

Mohr JP, Thompson JLP, Lazar RM, Levin B, Sacco RL, Furie KL,<br />

Kistler JP, Albers GW, Pettigrew LC, Adams HP, Jackson CM,<br />

Pullicino P (2001) A comparison of warfarin and aspirin <strong>for</strong><br />

the prevention of recurrent ischemic <strong>stroke</strong>. New England<br />

Journal of Medicine 345 (20): 1444–51.<br />

Molier BI, Van Asseldonk EH, Hermens HJ, Jannink MJ (2010)<br />

Nature, timing, frequency and type of augmented feedback:<br />

does it influence motor relearning of the hemiparetic arm<br />

after <strong>stroke</strong>? A systematic review. Disability and Rehabilitation<br />

32 (22): 1799–809.<br />

Molyneux AJ, Kerr RSC, Yu L, Clarke M, Sneade M, Yarnold JA,<br />

Sandercock P, <strong>for</strong> the Inter<strong>national</strong> Subarachnoid Aneurysm<br />

Trial (ISAT) Collaborative Group (2005) Inter<strong>national</strong><br />

subarachnoid aneurysm trial (ISAT) of neurosurgical clipping<br />

versus endovascular coiling in 2143 patients with ruptured<br />

intracranial aneurysms: a randomised comparison of effects<br />

on survival, dependency, seizures, rebleeding, subgroups, and<br />

aneurysm occlusion. Lancet 366 (9488): 809–17.<br />

Monga TN, Lawson JS, Inglis J (1986) Sexual dysfunction in<br />

<strong>stroke</strong> patients. Archives of Physical Medicine and<br />

Rehabilitation 67 (1): 19–22.<br />

Montane E, Vallano A, Laporte JR (2004) Oral antispastic drugs<br />

in nonprogressive neurologic diseases: a systematic review.<br />

Neurology 63 (8): 1357–63.<br />

Morris J, Oliver T, Kroll T, Macgillivray S (2012) The importance<br />

of psychological and social factors in influencing the uptake<br />

and maintenance of physical activity after <strong>stroke</strong>: a structured<br />

review of the empirical literature. Stroke Research and<br />

Treatment 2012: 195249.<br />

Morris PL, Robinson RG, Andrzejewski P, Samuels J, Price TR<br />

(1993) Association of depression with 10-year post-<strong>stroke</strong><br />

mortality. American Journal of Psychiatry 150 (1): 124–9.<br />

Mouradian MS, Majumdar SR, Senthilselvan A, Khan K, Shuaib A<br />

(2002) How well are hypertension, hyperlipidemia, diabetes,<br />

and smoking managed after a <strong>stroke</strong> or transient ischemic<br />

attack? Stroke 33 (6): 1656–9.<br />

National Audit Office (2005) Reducing brain damage: faster access<br />

to better <strong>stroke</strong> care. London: NAO.<br />

National Audit Office (2010) Progress in improving <strong>stroke</strong> care.<br />

London: NAO (www.nao.org.uk/publications/0910/<br />

<strong>stroke</strong>.aspx).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2003)<br />

Management of multiple sclerosis in primary and secondary<br />

care. London: NICE (www.nice.org.uk/nicemedia/live/10930/<br />

29199/29199.pdf).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2004)<br />

Supportive and palliative care <strong>for</strong> people with cancer: part A and<br />

part B. London: NICE (www.nice.org.uk/guidance/index.jsp?<br />

action=byId&o=10892&history=t).<br />

References<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2006a)<br />

Nutrition support in adults: oral nutrition support, enteral tube<br />

feeding and parenteral nutrition. London: NICE<br />

(www.nice.org.uk/CG32).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2006b)<br />

Supporting people with dementia and their carers in health and<br />

social care. London: NICE (http://guidance.nice.org.uk/CG42/<br />

NICEGuidance/pdf/English).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2006c) The<br />

management of atrial fibrillation. London: NICE<br />

(www.nice.org.uk/CG36).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2007a)<br />

Alteplase <strong>for</strong> the treatment of acute ischaemic <strong>stroke</strong>. London:<br />

NICE (www.nice.org.uk/TA122).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2007b)<br />

Faecal incontinence: the management of faecal incontinence in<br />

adults. London: NICE (www.nice.org.uk/CG49).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2007c)<br />

Secondary prevention in primary and secondary care <strong>for</strong><br />

patients following a myocardial infarction. London: NICE<br />

(www.nice.org.uk/CG48).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2008a)<br />

Cardiovascular risk assessment and the modification of blood lipids<br />

<strong>for</strong> the primary and secondary prevention of cardiovascular<br />

disease. London: NICE (www.nice.org.uk/CG67).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2008b)<br />

Diagnosis and initial management of acute <strong>stroke</strong> and transient<br />

ischaemic attack (TIA). London: NICE (www.nice.org.uk/<br />

CG68).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2009a)<br />

Depression: the treatment and management of depression in<br />

adults (update). London: NICE (www.nice.org.uk/CG90).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2009b)<br />

Functional electrical stimulation <strong>for</strong> drop foot of central<br />

neurological origin. London: NICE (www.nice.org.uk/<br />

nicemedia/live/11932/42902/42902.pdf).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2010a)<br />

Clopidogrel and modified-release dipyridamole <strong>for</strong> the<br />

prevention of occlusive vascular events (review of technology<br />

appraisal guidance 90). London: NICE (www.nice.org.uk/<br />

guidance/TA210).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2010b)<br />

Delirium: diagnosis, prevention and management. London:<br />

NICE (www.nice.org.uk/cg103).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2010c)<br />

Neuropathic pain: the pharmacological management of<br />

neuropathic pain in adults in non-specialist settings. London:<br />

NICE (www.nice.org.uk/CG96).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2010d)<br />

Stroke quality standard. London: NICE (www.nice.org.uk/<br />

guidance/qualitystandards/<strong>stroke</strong>/<strong>stroke</strong>qualitystandard.jsp).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2011)<br />

Hypertension: <strong>clinical</strong> management of primary hypertension<br />

in adults. London: NICE (http://guidance.nice.org.uk/<br />

CG127).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2012a)<br />

Atrial fibrillation – dabigatran exetilate. London: NICE<br />

(http://guidance.nice.org.uk/TA/Wave21/10).<br />

National Institute <strong>for</strong> Health and Clinical Excellence (2012b)<br />

Rivaroxaban <strong>for</strong> the prevention of <strong>stroke</strong> and systemic embolism<br />

in people with atrial fibrillation. London: NICE<br />

© Royal College of Physicians 2012 197

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!